Mostrar el registro sencillo del ítem
dc.contributor.author | El Aouad, Noureddine | es_ES |
dc.contributor.author | Berenguer, Inmaculada | es_ES |
dc.contributor.author | Romero, Vanessa | es_ES |
dc.contributor.author | Marin, Paloma | es_ES |
dc.contributor.author | Serrano, Angel | es_ES |
dc.contributor.author | Andujar, Sebastian | es_ES |
dc.contributor.author | Suvire, Fernando | es_ES |
dc.contributor.author | Bermejo, Almudena | es_ES |
dc.contributor.author | Ivorra, M. Dolores | es_ES |
dc.contributor.author | Enriz, Ricardo D. | es_ES |
dc.contributor.author | Cabedo Escrig, Nuria | es_ES |
dc.contributor.author | Cortes, Diego | es_ES |
dc.date.accessioned | 2016-07-08T10:58:16Z | |
dc.date.available | 2016-07-08T10:58:16Z | |
dc.date.issued | 2009-11 | |
dc.identifier.issn | 0223-5234 | |
dc.identifier.uri | http://hdl.handle.net/10251/67377 | |
dc.description.abstract | Two series of halogenated 1-benzyl-7-chloro-6-hydroxy-tetrahydroisoquinolines were prepared to explore the influence of each series on the affinity for dopamine receptors. All the compounds displayed a high affinity for D(1)-like and/or D(2)-like dopamine receptors in striatal membranes, although they were unable to inhibit [(3)H]-dopamine uptake in striatal synaptosomes. The halogen placed on the benzylic ring in 1-benzyl-THIQs, compounds of the series 1, 2'-bromobenzyl derivatives with K(i) values into the nanomolar range, and the series 2, 2',4'-dichlorobenzyl-THIQ homologues, proves to be an important factor to modulate affinity at dopamine receptor. (C) 2009 Elsevier Masson SAS. All rights reserved. | es_ES |
dc.description.sponsorship | This research was supported by the Spanish "Ministerio de Educacion y Ciencia" grant SAF 2007-63142. I. Berenguer acknowledges the fellowship of Generalitat Valenciana. S. Andujar acknowledges the fellowship of CONICET-Argentina. | en_EN |
dc.language | Inglés | es_ES |
dc.publisher | Elsevier | es_ES |
dc.relation.ispartof | European Journal of Medicinal Chemistry | es_ES |
dc.rights | Reserva de todos los derechos | es_ES |
dc.subject | 1-Halogenated benzyl-7-chloro-6-hydroxytetrahydroisoquinolines | es_ES |
dc.subject | Binding | es_ES |
dc.subject | Dopamine receptors | es_ES |
dc.subject | Dopamine uptak | es_ES |
dc.subject | Structure–activity relationships | es_ES |
dc.title | Structure-activity relationship of dopaminergic halogenated 1-benzyl-tetrahydroisoquinoline derivatives | es_ES |
dc.type | Artículo | es_ES |
dc.identifier.doi | 10.1016/j.ejmech.2009.06.033 | |
dc.relation.projectID | info:eu-repo/grantAgreement/MEC//SAF2007-63142/ES/SINTESIS DE ISOQUINOLEINAS DOPAMINERGICAS/ | es_ES |
dc.rights.accessRights | Cerrado | es_ES |
dc.contributor.affiliation | Universitat Politècnica de València. Instituto Agroforestal Mediterráneo - Institut Agroforestal Mediterrani | es_ES |
dc.description.bibliographicCitation | El Aouad, N.; Berenguer, I.; Romero, V.; Marin, P.; Serrano, A.; Andujar, S.; Suvire, F.... (2009). Structure-activity relationship of dopaminergic halogenated 1-benzyl-tetrahydroisoquinoline derivatives. European Journal of Medicinal Chemistry. 44(11):4616-4621. https://doi.org/10.1016/j.ejmech.2009.06.033 | es_ES |
dc.description.accrualMethod | S | es_ES |
dc.relation.publisherversion | http://dx.doi.org/10.1016/j.ejmech.2009.06.033 | es_ES |
dc.description.upvformatpinicio | 4616 | es_ES |
dc.description.upvformatpfin | 4621 | es_ES |
dc.type.version | info:eu-repo/semantics/publishedVersion | es_ES |
dc.description.volume | 44 | es_ES |
dc.description.issue | 11 | es_ES |
dc.relation.senia | 38606 | es_ES |
dc.contributor.funder | Ministerio de Educación y Ciencia | es_ES |
dc.contributor.funder | Generalitat Valenciana | es_ES |
dc.contributor.funder | Consejo Nacional de Investigaciones Científicas y Técnicas, Argentina | es_ES |